BioSpace News Archive

Business

CTI BioPharma Announces Appointment of Diane Parks to Its Board of Directors

CTI BioPharma Corp. announced the appointment of Diane Parks to its Board of Directors.

August 24, 2021
·
6 min read
Drug Development

BlueWillow Biologics Announces Positive Interim Results from Phase 1 Trial of Intranasal Anthrax Vaccine

BlueWillow Biologics, Inc. today announced positive interim results from the Phase 1 clinical trial of BW-1010, its next-generation intranasal anthrax vaccine candidate.

August 24, 2021
·
2 min read
Deals

Azurity Pharmaceuticals to Acquire and Merge with Arbor Pharmaceuticals

Azurity Pharmaceuticals, Inc. (“Azurity”) and Arbor Pharmaceuticals, Inc. (“Arbor”) today announced they have entered into a definitive agreement in which Azurity will be acquiring Arbor from existing investors including JW Asset Management and KKR.

August 24, 2021
·
6 min read
BioMidwest

Innovative Embolic Device for Treating Tumors Highlighted in “BEST of GEST” Session at the Global Embolization Oncology Symposium Technologies (“GEST”) Conference

Fluidx Medical Technology’s GPX Embolic Device was selected for a Global Embolization Oncology Symposium Technologies “BEST of GEST” session highlighting the technology’s ability to devascularize tumors during minimally-invasive transcatheter embolization procedures.

August 24, 2021
·
1 min read
Business

ASX Announcement: AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics

AdAlta and Carina Biotech enter a collaboration agreement to develop i-body enabled CAR-T cancer immunotherapies against up to five solid tumour antigen targets

August 24, 2021
·
7 min read
Business

Dasa expands partnership with SOPHiA GENETICS for the first decentralized cancer biomarker detection solution in Latin America

Dasa, the largest integrated healthcare network in Brazil, has chosen to expand upon its partnership with SOPHiA GENETICS SA (Nasdaq: SOPH) to offer the first decentralized HRD (Homologous recombination deficiency) analytics solution in Latin America.

August 24, 2021
·
4 min read
Drug Development

Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS Highlighting Preclinical Data for CTGF Inhibitor

Pieris Pharmaceuticals, Inc. announced today the presentation of preclinical data for PRS-220, a connective tissue growth factor (CTGF) inhibitor the Company is developing for the treatment of idiopathic pulmonary fibrosis (IPF)

August 24, 2021
·
5 min read
Biotech Beach

FDA Approves First COVID-19 Vaccine Which Can Be Distributed by Global WholeHealth Partners Corp (OTC: GWHP) as US Anticipates Considerable Uptick in Vaccination Rates, as Stated in 8K Filing 06/15/21

Global WholeHealth Partners Corp. (OTC: GWHP) is readying for sales due to the transition from Emergency Use Status to Full FDA Approval of Vaccine developed by Pfizer-BioNTech, as stated in 8K filing 06/15/21.

August 24, 2021
·
7 min read
Ibex Introduces Galen Gastric, World’s First AI-powered Solution for Gastrointestinal Cancer Diagnostics, at Maccabi Healthcare Services

Ibex Medical Analytics today announced the deployment of Galen™ Gastric at Maccabi’s pathology institute, making it the first laboratory in the world to use AI for detecting cancer in the gastrointestinal (GI) tract.

August 24, 2021
·
5 min read
Applications of Bioluminescent Research Tools Showcased at Global Seminar Series

Life science and drug discovery researchers interested in bioluminescent tools will have the opportunity to hear from global thought leaders on the possibilities and applications of luciferase technologies during the upcoming Discover Glo 2021 virtual seminar series.

August 24, 2021
·
4 min read